AUROPHARMA.NS
Aurobindo Pharma Ltd
Price:
1,172.9
INR
Volume:
1,501,372
India | Pharmaceuticals
No data available for this ticker
AUROPHARMA.NS Probability of Bankruptcy
The Probability of Bankruptcy of Aurobindo Pharma Ltd (AUROPHARMA.NS) is 0% . This number represents the probability that AUROPHARMA.NS will face financial distress in the next 24 months given its current fundamentals and market conditions.
Multiple factors are taken into account when calculating AUROPHARMA.NS's probability of bankruptcy : Altman Z-score, Beneish M-score, financial position, macro environments, academic research about distress risk and more.
AUROPHARMA.NS - Historical Solvency Measures
to of
Page of
AUROPHARMA.NS - ESG ratings
ESG ratings are directly linked to the cost of capital and AUROPHARMA.NS's ability to raise funding, both of which can significantly affect the probability of Aurobindo Pharma Ltd going bankrupt.
ESG Score
64.61
Environment Score
59.7
Social Score
74.55
Governance Score
59.59
| Returns | |
| Historical Returns (5 day) | -0.32% |
| Historical Returns (MTD) | -1.71% |
| Historical Returns (YTD) | -10.06% |
| Historical Returns (13 week) | 0.78% |
| Historical Returns (26 week) | -13.9% |
| Historical Returns (52 week) | 1.68% |
| Efficiency | |
| Asset Turnover | 0.33 |
| Receiveable Turnover | 6.04 |
| Gross Margin | 59.1% |
| Operating Margin | 15.6% |
| Pretax Margin | 16% |
| Net Margin | 11.3% |
| Return on Asset (ROA) | 3.71 |
| Return on Equity (ROE) | 5.69 |
| Return on Investments (ROI) | 4.55 |
| Price Metrics | |
| Market Cap (M) | 681,220.3 |
| Enterprise Value (M) | 697,095.8 |
| 52 Week High | 1,592 |
| 52 Week Low | 1,010 |
| Beta | 1.14 |
| Average Volume (10 day) | 1.17 |
| Average Volume (3 month) | 1.14 |
| Price / Earnings (P/E) | 20.2 |
| Price / Sales (P/S) | 2.3 |
| Earnings | |
| EPS | 59.81 |
| Revenue CAGR (5 year) | 8.19% |
| Risk | |
| Current Ratio | 1.83 |
| Quick Ratio | 1.1 |
AUROPHARMA.NS - Peer Comparisons
| Ticker | Company Name | Beta | Probability of Bankruptcy |
| a |